Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2003-08-13
2010-10-12
Navarro, Mark (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S135100
Reexamination Certificate
active
07812134
ABSTRACT:
The present invention relates to methods for the control of virulence of infectious bacteria by modulating the extra-cellular concentration of bacterial cell signalling molecules. Derivatives of cell signalling molecules are conjugated to suitable carrier proteins and used to isolate high affinity receptors recognising the native signal molecule(s). By binding to signalling molecules, the receptors reduce and maintain extra-cellular concentrations of signal molecules below the threshold level that would otherwise result in certain opportunistic pathogens adopting a virulent form, and can transform virulent organisms to non-virulent states. These receptors have applications for the treatment of individuals with susceptibility to infection, the treatment of patients with existing infections, in disease monitoring and management, and in related applications where the host for infection is an animal or plant.
REFERENCES:
patent: 5254671 (1993-10-01), Chang
patent: 6395282 (2002-05-01), Kende et al.
patent: 6703513 (2004-03-01), Quay
patent: 6713059 (2004-03-01), Kende et al.
patent: 7384639 (2008-06-01), Kende et al.
patent: 2003/0095985 (2003-05-01), Kende et al.
patent: 2002-514092 (2002-05-01), None
patent: 98/58075 (1998-12-01), None
patent: WO 99/27786 (1999-06-01), None
patent: WO 01/94543 (2001-12-01), None
patent: 2002/018342 (2002-03-01), None
patent: 2004/014423 (2004-02-01), None
McCafferty et al (Nature vol. 348, No. 6301, pp. 552-554, Dec. 1990).
Charlton et al., “The isolation of super-sensitive anti-hapten antibodies from combinatorial antibody libraries derived from sheep,”Biosensors&Bioelectronics(2001)16:639-646.
Chen et al., “Structural identification of a bacterial quorum-sensing signal containing boron,”Nature(2002) 415:545-549.
Dong et al., “Quenching quorum-sensing-dependent bacterial infection by anN-acyl homoserie lactonase,”Nature(2001) 411:813-817.
Finch et al., “Quorum sensing: a novel target for anti-infective therapy,”J. of Antimicrobial Chemotherapy(1998) 42:569-571.
Hartman et al., “Quorum sensing: potential means for treating gram-negative infections?”The Lancet(1998)351:848-849.
Mayville “Structure-activity analysis of synthetic autoinducing thiolactone peptides fromStaphylococcus aureusresponsible for virulence,”PNAS USA(1999) 96:1218-1223.
Moghaddam et al., “Identification of scFv antibody fragments that specifically recognize the heroin metabolite 6-monoacetylmorphine but not morphine,”J. Immunological Methods(2003) 280:139-155.
Moghaddam et al., “Selection and characterization of recombinant single-chain antibodies to the hapten Aflatoxin-B1 from naïve recombinant antibody libraries,”J. Immunological Methods(2001) 254:169-181.
Reverchon et al., “New synthetic analogues ofN-acyl homoserine lactones as agonists or antagonists of transcriptional regulators involved in bacterial quorum sensing,”Bioorganic&Medicinal Chemistry Letters(2002) 12:1153-1157.
Wu et al., Detection ofN-acylhomoserine lactones in lung tissues of mice infected withPseudomonas aeruginosa(2000) 146:2481-2493.
International Search Report dated Dec. 12, 2003 for International Application No. PCT/GB03/03529.
Non-Final Office Action dated Jul. 13, 2009 in co-pending U.S. Appl. No. 10/599,355.
D'Argenio, et al., Autolysis and autoaggregation inPseudomonas aeruginosacolony morphology mutants, Journal of Bacteriology, 2002;184(23):6481-6489.
McGrath, et al., Dueling quorum sensing sytems inPseudomonas aeruginosacontrol the production of thePseudomonas quinolonesignal (PQS), FEMS Microbiology Letter, 2003;230(1):27-34.
Charlton Keith Alan
Porter Andrew Justin Radcliffe
Haptogen Ltd.
Navarro Mark
Pepper Hamilton LLP
LandOfFree
Methods for the treatment of an infectious bacterial disease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the treatment of an infectious bacterial disease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of an infectious bacterial disease... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4198442